Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361817772> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4361817772 abstract "<div>Abstract<p><b>Purpose:</b> To develop new therapies for children with solid tumors, we tested the cytotoxicity of natural killer (NK) cells expanded by coculture with K562-mb15-41BBL cells. We sought to identify the most sensitive tumor subtypes, clarify the molecular interactions regulating cytotoxicity, and determine NK antitumor potential <i>in vivo</i>.</p><p><b>Experimental Design:</b> We tested <i>in vitro</i> cytotoxicity of expanded NK cells against cell lines representative of Ewing sarcoma (EWS; <i>n</i> = 5), rhabdomyosarcoma (<i>n</i> = 4), neuroblastoma (<i>n</i> = 3), and osteosarcoma (<i>n</i> = 3), and correlated the results with expression of inhibitory and activating NK receptor ligands. We also compared expanded and primary NK cells, determined the effects of activating receptor ligation and of chemotherapeutic drugs, and assessed the therapeutic effect of NK cell infusions in xenografts.</p><p><b>Results:</b> In 45 experiments, EWS and rhabdomyosarcoma cell lines were remarkably sensitive to expanded NK cells, with median cytotoxicities at 1:1 effector/target ratio of 87.2% and 79.1%, respectively. Cytotoxicity was not related to levels of expression of NK receptor ligands, nor was it affected by pretreatment of target cells with daunorubicin or vincristine, but was markedly inhibited by preincubation of NK cells with a combination of antibodies against the NK-activating receptors NKGD2 and DNAM-1. Expanded NK cells were considerably more cytototoxic than unstimulated NK cells, and eradicated EWS cells engrafted in nonobese diabetic/severe combined immunodeficient Il2rgnull mice.</p><p><b>Conclusions:</b> Among pediatric solid tumors, EWS and rhabdomyosarcoma are exquisitely sensitive to expanded NK cells. The NK expansion method described here has been adapted to large-scale conditions and supports a phase I clinical study including patients with these malignancies. Clin Cancer Res; 16(15); 3901–9. ©2010 AACR.</p></div>" @default.
- W4361817772 created "2023-04-05" @default.
- W4361817772 creator A5035803842 @default.
- W4361817772 creator A5040880742 @default.
- W4361817772 creator A5058001607 @default.
- W4361817772 creator A5065331155 @default.
- W4361817772 creator A5068463807 @default.
- W4361817772 creator A5079486647 @default.
- W4361817772 date "2023-03-31" @default.
- W4361817772 modified "2023-09-27" @default.
- W4361817772 title "Data from Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors" @default.
- W4361817772 doi "https://doi.org/10.1158/1078-0432.c.6519159.v1" @default.
- W4361817772 hasPublicationYear "2023" @default.
- W4361817772 type Work @default.
- W4361817772 citedByCount "0" @default.
- W4361817772 crossrefType "posted-content" @default.
- W4361817772 hasAuthorship W4361817772A5035803842 @default.
- W4361817772 hasAuthorship W4361817772A5040880742 @default.
- W4361817772 hasAuthorship W4361817772A5058001607 @default.
- W4361817772 hasAuthorship W4361817772A5065331155 @default.
- W4361817772 hasAuthorship W4361817772A5068463807 @default.
- W4361817772 hasAuthorship W4361817772A5079486647 @default.
- W4361817772 hasBestOaLocation W43618177722 @default.
- W4361817772 hasConcept C109316439 @default.
- W4361817772 hasConcept C153911025 @default.
- W4361817772 hasConcept C185592680 @default.
- W4361817772 hasConcept C202751555 @default.
- W4361817772 hasConcept C2778102761 @default.
- W4361817772 hasConcept C502942594 @default.
- W4361817772 hasConcept C55493867 @default.
- W4361817772 hasConcept C86803240 @default.
- W4361817772 hasConcept C98274493 @default.
- W4361817772 hasConceptScore W4361817772C109316439 @default.
- W4361817772 hasConceptScore W4361817772C153911025 @default.
- W4361817772 hasConceptScore W4361817772C185592680 @default.
- W4361817772 hasConceptScore W4361817772C202751555 @default.
- W4361817772 hasConceptScore W4361817772C2778102761 @default.
- W4361817772 hasConceptScore W4361817772C502942594 @default.
- W4361817772 hasConceptScore W4361817772C55493867 @default.
- W4361817772 hasConceptScore W4361817772C86803240 @default.
- W4361817772 hasConceptScore W4361817772C98274493 @default.
- W4361817772 hasLocation W43618177721 @default.
- W4361817772 hasLocation W43618177722 @default.
- W4361817772 hasOpenAccess W4361817772 @default.
- W4361817772 hasPrimaryLocation W43618177721 @default.
- W4361817772 hasRelatedWork W1997829619 @default.
- W4361817772 hasRelatedWork W2033530968 @default.
- W4361817772 hasRelatedWork W2048313550 @default.
- W4361817772 hasRelatedWork W2085647549 @default.
- W4361817772 hasRelatedWork W2090296219 @default.
- W4361817772 hasRelatedWork W2118721040 @default.
- W4361817772 hasRelatedWork W2416964709 @default.
- W4361817772 hasRelatedWork W2946316715 @default.
- W4361817772 hasRelatedWork W2953711826 @default.
- W4361817772 hasRelatedWork W2739218524 @default.
- W4361817772 isParatext "false" @default.
- W4361817772 isRetracted "false" @default.
- W4361817772 workType "article" @default.